+143.3%
MRNA vs FITB
+19.4%
+123.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | FITB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.6% | -2.8% | -4.6% |
| 7D | -10.1% | -0.4% | -9.7% | -10.8% |
| 30D | +126.7% | -5.1% | +131.9% | +112.0% |
| 3M | +184.1% | +3.5% | +180.6% | +156.9% |
| 6M | +143.3% | +17.2% | +126.1% | +100.3% |
| All | +143.3% | +19.4% | +123.9% | +100.3% |
Cumulative growth
Daily Returns
Daily percentage return beside FITB.
Daily Out/Under-Performance
Portfolio return minus FITB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FITB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded FITB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling